Meningococcal Infections
📧 Sign up to get email alerts when something new happens for Meningococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014 [Phase 3]
Phase 3 trial update evaluating safety of GSK vaccine given at 12-15 months and 15-18 months post-priming with GSK vaccine 792014 for mening…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults [Phase 3]
A Phase 3 trial assessing lot consistency, immunogenicity, and safety of the meningococcal vaccine GSK134612 given with Fluarix in adults ag…
-
CLINICAL_TRIALS research · 2012-03-27Clinical Trial Update: B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors
A terminated prevalence study investigating meningococcal carriage and risk factors in the Seine-Maritime population.
-
CLINICAL_TRIALS research · 2012-03-27Clinical Trial Update: Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection
A completed clinical trial entry describing the creation of a biobank of patients from Seine-Maritime with meningococcal infection, sponsore…
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children [Phase 3]
Phase 3 trial results assessing the safety and immune response of the MenACWY conjugate vaccine in healthy children have been completed and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults [Phase 3]
Phase 3 trial evaluating the safety and immune response of the Novartis Meningococcal ACWY conjugate vaccine (Menveo) in US adolescents and …
-
CLINICAL_TRIALS trial_result · 2010-08-04Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults [Phase 3]
Phase 3 trial update evaluating safety and immune response of the Novartis meningococcal ACWY vaccine in healthy adults. The study is comple…
-
CLINICAL_TRIALS trial_result · 2010-03-25Clinical Trial Update: Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years [Phase 1, Phase 2]
Phase 1/2 exploratory trial assessing safety and immunogenicity of Menactra and Menomune in people aged 56 and older; results were posted in…
-
CLINICAL_TRIALS trial_result · 2009-12-14Clinical Trial Update: Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune® [Phase 2]
Phase 2 trial assessing how long antibodies persist after a single dose of Menactra or Menomune in adolescents and adults aged 15 to 23.
-
CLINICAL_TRIALS trial_result · 2009-04-30Clinical Trial Update: Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune® [Phase 4]
Phase 4 clinical trial assesses safety and immunogenicity of intradermal versus subcutaneous dosing of Menomune for meningococcal infections…
-
CLINICAL_TRIALS trial_result · 2006-12-22Clinical Trial Update: Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine [Phase 4]
A Phase 4 clinical trial of a fractional-dose tetravalent meningococcal polysaccharide vaccine (serogroups A, C, Y, W135) has completed.